Search Results 231-240 of 16250 for VEO-IBD

  1. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

    * Has diagnosis of ulcerative colitis (UC) or indeterminate colitis. * Has CD isolated to the stomach, duodenum, jejunum, or perianal region, without ...

  2. A Study to Determine the Differences in Microbiota Composition in Patients With and Without Post-Infection Irritable Bowel Syndrome - Mayo Clinic

    jejuni, IBD (Crohn's disease or ulcerative colitis), microscopic colitis, or celiac disease; History of laboratory confirmed gastroenteritis in six months ...

  3. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Is a hepatitis B immunity check needed for IBD patients? · Leading scientists share advances in Omics-based clinical trials at 12th Annual ...

  4. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? · Leading scientists share advances in Omics-based clinical trials at 12th Annual Individualizing ...

  5. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

    IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are currently not available. More about research ...

  6. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  7. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  8. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? Katie Helwig. May 4, 2023. Leading scientists share advances in ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    Fecal calprotectin testing is optional and should only be considered if there is a strong suspicion that the subject has IBD (e.g., family history in a 1st ...

  10. Publications - Kevin T. Behm, M.D. - Mayo Clinic

    ... Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study. Dis Colon Rectum. 2024 Nov 1; 67 (11):1443-1449 Epub 2024 Aug 01. View PubMed ...